SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Pyxis Oncology to Present Phase 1 MICVO Monotherapy Data

Pyxis Oncology said Phase 1 monotherapy data for micvotabart pelidotin will be featured at EORTC-NCI-AACR.

PYXS

Related stories